Skip to Main Content

Paper Details

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
Br J Cancer
9
2023
Author NameAffiliation
Paul J HergenrotherInc.
Paul J HergenrotherCancer Center at Illinois
Paul J HergenrotherInstitute for Genomic Biology, University of Illinois
Paul J HergenrotherUniversity of Illinois
  • 1 - 4

Datasets

Release 1.2